Skip to main content

This is a preprint.

It has not yet been peer reviewed by a journal.

The National Library of Medicine is running a pilot to include preprints that result from research funded by NIH in PMC and PubMed.

bioRxiv logoLink to bioRxiv
[Preprint]. 2025 Jun 19:2025.06.18.660387. [Version 1] doi: 10.1101/2025.06.18.660387

Cross-feeding interactions between Fusobacterium nucleatum and the glycan forager Segatella oris

Joshua R Fletcher a,#, Ryan C Hunter b
PMCID: PMC12224549  PMID: 40611897

Abstract

Fusobacterium nucleatum is a common member of the oral microbiota frequently associated with extraoral infections and diverse polymicrobial environments, including chronic airway diseases and colorectal tumors. Yet, its interactions with co-colonizing microbiota remain poorly defined. Here, we investigate cross-feeding interspecies dynamics between F. nucleatum and Segatella oris, a glycan-foraging anaerobe enriched in airways and gastrointestinal tumors. Using broth cultures, cell-free supernatants, and co-culture on primary human airway epithelial cells, we identify bidirectional interactions that shape nutrient acquisition, biofilm formation, gene expression, and host responses. While mucin or S. oris supernatants modestly enhanced F. nucleatum growth, both conditions triggered transcriptional remodeling, including induction of the nan operon for sialic acid catabolism, suggesting reliance on glycan degradation by S. oris. Conversely, S. oris exhibited differential expression of multiple polysaccharide utilization loci (PULs) when exposed to F. nucleatum or its metabolites. Biofilm formation by F. nucleatum was strongly inhibited by S. oris, indicative of antagonistic interactions. Dual and triple RNA-seq revealed that epithelial responses were predominately shaped by F. nucleatum, with enrichment of inflammatory and cancer-associated pathways; however, co-colonization with S. oris modulated the magnitude and specificity of host gene expression. These findings demonstrate that glycan-mediated cross-feeding and microbial interactions shape the physiology and pathogenic potential of F. nucleatum in mucosal environments. This work underscores the importance of modeling polymicrobial communities under host-relevant conditions to better understand pathobiont behavior at the epithelial interface.

Keywords: Fusobacterium nucleatum, Segatella oris, Prevotella oris, cross-feeding, glycans, microbiome, chronic airway disease, transcriptomics

Introduction

Fusobacterium nucleatum is a Gram-negative member of the oral microbiota that contributes to biofilm assembly, architecture, and community organization (1, 2). Although best known for its roles in dental plaque and periodontal disease, F. nucleatum is implicated in a range of extraoral infections and is frequently detected in tumors across multiple cancer types (3–6). While it can function as both a commensal and pathogen, F. nucleatum is often found in diverse polymicrobial host environments, including colorectal tumors and the airways of individuals with chronic rhinosinusitis (CRS), cystic fibrosis (CF), or chronic obstructive pulmonary disease (COPD) (7–14). This raises questions about whether and how F. nucleatum interacts with co-colonizing microbiota and how these interactions shape its behavior and pathogenic potential. Equally important is understanding how F. nucleatum influences the activity of other taxa in these communities, many of which also exhibit context-dependent commensal or pathogenic behavior (15).

Segatella oris (formerly Prevotella oris) is also a member of the oral microbiota, though less is known about its physiology or microbial interactions. Notably, S. oris supernatants inhibit growth of the airway pathogen Moraxella catarrhalis in vitro, suggesting a connection between S. oris residence in the upper airways and colonization resistance against some pathogens (16). However, S. oris also exhibits pathogenic traits, including hemolysin production with activity against human erythrocytes (17). Like F. nucleatum, it is detected in extraoral infections, gastric tumors, CRS and CF airway mucus, and is co-enriched with F. nucleatum in the oral microbiomes of cancer patients with chemotherapy-induced oral mucositis (9, 18, 19). More broadly, both Fusobacterium and Prevotella genera are co-detected in esophageal tumors (20), suggesting that cross-feeding interactions between these taxa may facilitate colonization and promote disease.

Although environmental conditions vary across infection sites, shared features such as host glycans, proteoglycans, and glycosaminoglycans are common. This is particularly true in mucus-laden airways of patients with chronic respiratory diseases and the mucus layer lining the intestinal tract, where F. nucleatum has been detected (21). F. nucleatum primarily ferments amino acids to generate ATP, although glucose and fructose metabolism have also been reported (22–26). While it produces intracellular polyglucose granules in vitro, the genetic basis and functional significance of this pathway, including possible links to virulence, remain unclear (27). Notably, F. nucleatum lacks sialidases and polysaccharide utilization loci (PULs), but can scavenge sialic acids liberated by glycan foraging microbes (28), potentially enhancing community persistence through cross-feeding. In contrast, the S. oris NCTC 13071 genome encodes 27 predicted PULs, likely involved in sensing, importing, and degrading of complex polysaccharides such as mucins and other host glycans (29, 30).

Given their frequent co-occurrence in mucin-rich environments in vivo and the possible complementarity of their metabolic repertoires, we hypothesized that F. nucleatum and S. oris engage in cross-feeding interactions. To test this, we examined how each species adjusts its growth and gene expression to mucin glycoproteins and each other’s metabolic byproducts. We found that while neither mucins nor S. oris supernatant substantially altered the growth of F. nucleatum, both conditions triggered significant transcriptional changes. Conversely, S. oris exhibited distinct growth dynamics and widespread transcriptional responses in mucin and F. nucleatum supernatants. Although F. nucleatum forms robust biofilms, biofilm formation was greatly reduced in S. oris supernatants and in co-culture, despite biofilm growth in mucin or control media. We further extended these analyses using co-culture of each species, individually and together, on the apical surface of primary human airway epithelial cells to model aspiration-based colonization relevant to CF, CRS, and COPD. Dual (host-S. oris, host-F. nucleatum), and triple (host-S. oris-F. nucleatum) RNA sequencing revealed that host-associated growth conditions strongly influence bacterial gene expression, including unexpected variability in S. oris PUL expression mediated by F. nucleatum. Host transcriptomic responses were primarily driven by F. nucleatum, with prominent induction of pro-inflammatory mediators TNFA and TNFAIP2, as well as several genes linked to cancer. Together, these data capture key information about bacterial interactions on relevant host cell types and highlight how co-colonizing, cross-feeding partners may modify each other’s physiology and influence host responses.

Materials and methods

Bacterial strains and media conditions.

Fusobacterium nucleatum subsp. nucleatum strain ATCC 25586 and Segatella oris strain NCTC13071 were propagated anaerobically in a Coy anaerobic chamber using BBL Brucella broth (BD) or 1.5% agar plates supplemented with hemin (250 μg/mL) and vitamin K (50 μg/mL) (Hardy Diagnostics). A semi-defined control medium was prepared by combining Brucella Broth with minimal salts (50:50) as previously described (31). A minimal mucin medium (MMM) was generated by autoclaving porcine gastric mucin (PGM, Sigma) at 30 g/L in water, diluting to 15 g/L in 2X minimal salts, and combining 1:1 with Brucella broth to yield the final mucin-containing experimental medium (hereafter referred to as mucin medium), adapted from Flynn et al. (32) with dialysis steps omitted. Cell-free supernatants (CFS) were prepared in biological triplicate by culturing each strain for 48 h in mucin medium (10 mL) under anaerobic conditions. Cultures were centrifuged at 4,000 rpm at 4°C for 20 min, and the resulting supernatants were then passed through 0.22 μm filters. CFS were stored at −80°C and thawed once immediately prior to use.

Growth curves.

F. nucleatum and S. oris were grown overnight in Brucella Broth supplemented with hemin (0.35 mg/mL) and vitamin K (0.05 mg/mL), then subcultured 1:5 in fresh medium and grown for an additional 4h. Optical density at 600 nm (OD600) was determined via spectrophotometry and adjusted to 0.01 in the respective growth medium. 200 μL of each culture was added to individual wells in a clear, flat-bottomed 96-well plate in technical triplicate across three biological replicates. Plates were sealed with a Breathe-Easy gas-permeable membrane and incubated in a Tecan Sunrise plate reader in the anaerobic chamber at 37°C for 72h. OD600 was recorded hourly following 5 seconds of linear shaking.

Biofilm assays.

Biofilm assays were performed in parallel using identical media conditions as described for growth curves, following the protocol of Merritt et al (33). Briefly, microtitre plates were inoculated with each species individually or in co-culture and incubated anaerobically at 37°C for 48 h. Following incubation, plates were removed from the chamber and planktonic cultures were discarded. Plates were washed three times with 250 μL water, stained with 200 μL 0.1% crystal violet (in water) for 15 minutes, then washed again three times and air-dried overnight. Crystal violet was solubilized with 200 μL of 30% acetic acid, and absorbance at 550 nm was determined using a BioTek Synergy H1 microplate reader. Wells containing sterile media were used as negative controls for background subtraction.

Colonization of primary human airway epithelial monolayers.

Normal human bronchial epithelial (NHBE) cells (Lonza Bioscience), obtained from healthy donors were expanded B-ALI Growth Basal Medium (Lonza) and seeded on 6.5 mm Transwell inserts (0.4 um pore; STEMCELL Technologies). Upon reaching confluency after ~2–4 days post-seeding, apical medium was removed, and basolateral medium was replaced with B-ALI Differentiation Basal Medium (Lonza). Cells were maintained at air-liquid interface (ALI) for 3–4 weeks at 37°C and 5% CO2 in a humidified incubator.

Overnight bacterial cultures were grown in Brucella Broth supplemented with hemin and vitamin K. These were subcultured 1:5 in fresh medium and grown to OD600 = 0.5. Cultures were diluted 1:10 into infection medium (DMEM supplemented with 2% FBS, 10mM HEPES, 0.1 mM nonessential amino acids, 4 mM L-glutamate, and 1mM sodium pyruvate). 100 μL of bacterial suspension was applied to the apical surface of each Transwell and incubated for 4 h at 37°C under anaerobic conditions. After incubation, apical supernatants were gently removed by pipette, and co-cultures were maintained for an additional 24h prior to RNA extraction.

RNA extraction.

Each species was grown in 10 mL of control, mucin, and CFS media in 15 mL conical Falcon tubes for 24h and collected by centrifugation at 4,000 rpm for 20 min at 4°C. Pellets were dissolved by gentle pipetting in 1 mL of TRIzol Reagent (ThermoFisher). For airway epithelial co-cultures, 250 μL TRIzol was added to the apical surface and a 1 mL pipette tip was used to scrape cellular material from the transwell surface. Scraping was performed four times per insert to yield 1 mL of total lysate in TRIzol. All TRIzol samples were incubated for 5 minutes at room temperature, followed by addition of 200 μL chloroform, hand agitation for 15 s, followed by another 5-minute incubation on the benchtop. Phase separation was performed by centrifugation at 12,000 rpm for 15 minutes at 4°C. The aqueous phase was mixed 1:1 with 95% ethanol and RNA was column purified with the Zymo Clean & Concentrator-5 kit including an on-column DNase-I treatment according to manufacturer’s instructions.

RNA sequencing and analysis.

Total RNA from broth cultures was submitted to Seq Center (Pittsburgh, PA), where rRNA depletion was performed with the Illumina Stranded Total RNA Prep with Ribo-Zero Plus Microbiome kit prior to library preparation and sequencing (2 × 150 bp). RNA from bacterial and epithelial co-cultures was sent to SeqCoast Genomics (Portsmouth, NH). rRNA depletion was also performed on these samples prior to Illumina sequencing (2 × 150 bp). Sequencing was performed on the Illumina NextSeq2000 platform with a 300 cycle flow cell kit. Read quality was assessed using FastQC (https://www.bioinformatics.babraham.ac.uk/projects/fastqc/). Given the consistently high quality and the risk of biasing downstream analyses (34), no read trimming was performed.

For bacterial RNA seq, coding sequences for all annotated genes and riboswitches, gene names, and locus tags were extracted from the F. nucleatum ATCC 25586 (NZ_CP028101) and S. oris NCTC 17031 (NZ_LR134384) genomes in Geneious Prime (2024.0.7) and converted to FASTA format via the “Tabular-to-fasta” tool via the Galaxy server (https://usegalaxy.org/), and indexed with Salmon (35) for quasi-mapping of reads. For host RNA-seq, the Homo sapiens transcriptome (GRCh38.p14, release 45) was retrieved from Gencode (https://www.gencodegenes.org/human/release_45.html). Transcriptome indices were built in Salmon, to which reads were quasi-mapped. The quant.sf files generated by Salmon were imported into RStudio via the tximport package (36) and differential expression analysis was performed with DESeq2 (37). The threshold for differential expression was a log2 fold change ≥1 at an adjusted p-value <0.05. Code for each analysis is available at https://github.com/Hunter-Lab-UMN/Fletcher_FnSo_2025.

Data availability.

All sequencing files are available at the NCBI Sequence Read Archive (SRA) under accession number PRJNAXXXXX.

Results

Growth and biofilm formation of F. nucleatum and S. oris are influenced by mucin and cross-feeding in vitro.

F. nucleatum and S. oris were cultured under three conditions: (i) control medium, (ii) control medium supplemented with porcine gastric mucin (hereafter “mucin medium” or “mucin”), or (iii) cell-free supernatants (CFS) derived from each species grown in mucin for 48h. In control medium, F. nucleatum exhibited distinct growth phases with a pronounced exponential phase followed by stationary and death phases, with optical density remaining consistent after ~36h. Exponential growth rates were similar across conditions; however, cultures grown in mucin or S. oris CFS reached higher stationary-phase densities and exhibited a slower decline during death phase compared to controls (~12–36h, Fig. 1A). This elevated density in mucin was sustained until ~60h, after which it declined to control levels. Area under the curve (AUC) analysis reflected this trend, with mucin medium showing a modest, though not statistically significant, increase relative to the control (p=0.0951, Fig. 1B). In contrast, F. nucleatum density in S. oris CFS declined sharply after 48h, yielding an AUC comparable to the control.

Fig. 1. Mucin and interspecies metabolite exchange influence growth and biofilm formation of F. nucleatum and S. oris.

Fig. 1.

(A) Growth curves of F. nucleatum in control medium, mucin medium, and S. oris cell-free supernatants (CFS) (n=3). (B) Area under the curve (AUC) analysis for F. nucleatum growth. (C) Biofilm formation by F. nucleatum in each condition after 48h, quantified by crystal violet staining. (D) Growth curves of S. oris in control medium, mucin medium, and F. nucleatum CFS. (E) AUC analysis for S. oris growth. (F) Biofilm formation by S. oris across all conditions. Data represent the mean of three biological replicates +/− standard error of the mean (n=3). Statistical significance in panels B,C,E,F was determined using ordinary one-way ANOVA with Tukey’s multiple comparisons test.

Biofilm formation by F. nucleatum was robust in both control and mucin media, with a trend toward increased biofilm in mucin. However, biofilm growth was nearly abolished in S. oris CFS (Fig. 1C). This suppression is unexpected given F. nucleatum’s well-established role as a so-called “bridging” species in the highly structured and spatially stratified polymicrobial biofilms of the oral cavity (38).

In contrast, S. oris exhibited markedly different growth dynamics across conditions. Growth in control medium was slow with apparent diauxie following a brief stationary phase at ~24h, a second exponential phase, and final plateau at ~40h (Fig. 1D). In mucin medium, S. oris grew much more rapidly, reaching a higher maximum density and exhibiting a three-fold increase in AUC compared to the control (Fig. 1E). These findings are consistent with genomic predictions of glycan utilization via PULs. Growth in F. nucleatum CFS yielded a faster growth rate than control medium but lower stationary phase density than mucin; AUC for CFS and control were comparable. Biofilm formation by S. oris was minimal in the control medium and nearly undetectable in mucin or CFS conditions (Fig. 1F). In dual-species cultures grown in control or mucin media, biofilms phenocopied the minimal single-species biofilms of S. oris (Suppl. Fig. 1).

F. nucleatum and S. oris transcriptomes are modulated by mucin, cross-feeding, and interactions with human airway epithelia.

Both species exhibited growth phenotypes responsive to the nutritional composition of each medium (Fig. 1). Mucin supplementation modestly enhanced F. nucleatum growth but had a pronounced effect on S. oris, suggesting species-specific nutrient utilization. Growth in CFS derived from either species grown in mucin medium was comparable to or greater than growth in the control medium, indicating that neither species fully exhausted nutrients essential to the other. Interestingly, S. oris growth was diminished in F. nucleatum CFS compared to mucin, despite F. nucleatum lacking known glycan-degrading capabilities. Given their potential clinical relevance and prevalence of each species in chronic airway disease, we also sought to connect broth culture data to more physiologically relevant conditions with host airway epithelia. To model how each species influences the host airway response to colonization, we employed a Dual Oxic-Anoxic Co-Culture (DOAC) model recently developed by our group, in which oxygen-dependent airway epithelial cells are supplied oxygenated blood gas basolaterally while exposing their apical surfaces to the anaerobic chamber environment (39). This advancement allows for colonization and growth of obligate anaerobes on epithelial cells, enabling study of host-pathogen-microbiota interactions. We performed RNA-seq on each bacterium in control, mucin, and CFS media, as well as dual- and triple- RNA-seq on primary normal human bronchial epithelial (NHBE) cells challenged with each bacterium alone or in co-culture for 24h. This allowed us to determine how different growth environments affect expression of genes involved in nutrient acquisition and metabolism. Differentially expressed genes are provided in Supplementary Files 1 (F. nucleatum) and 2 (S. oris). Principal components analysis (Figs 2A and 3A) revealed that the greatest transcriptomic separation occurred between broth cultures media and airway epithelial co-cultures, with CFS exerting the most pronounced transcriptional shift among media conditions.

Figure 2 -. Transcriptomic responses of F. nucleatum to mucin, S. oris supernatants, and epithelial co-culture.

Figure 2 -

is A) Principal component analysis (PCA) of F. nucleatum transcriptomes across control medium, mucin medium, CFS from S. oris grown in mucin medium, on normal human bronchial epithelia individually or in co-culture with S. oris. (B) Heatmap of amino acid transporter gene expression across conditions. (C) Expression of sialic acid catabolism (nan operon) genes. (D) Expression of glycogen metabolism genes (see Supplemental Files for complete gene lists). Each column in the heatmaps is an individual biological replicate and each row is a transcript. Normalized read counts from DESeq2 are scaled by row and presented as Z-scores.

Figure 3 -. The S. oris transcriptome is significantly altered across media and co-culture conditions in vitro.

Figure 3 -

A) PCA of S. oris transcriptomes, colored by growth medium or co-culture status on NHBE. across growth conditions. lot depicting the transcriptome of individual S. oris samples, which are colored by growth medium or co-culture status on NHBE. Heatmaps of B) average expression of every gene in a given PUL across conditions, C) PUL 7, and D) PUL 8 in S. oris. Data are scaled by row and presented as Z-scores. Statistical significance for PUL expression comparisons provided in Suppl File Z.

F. nucleatum amino acid uptake and metabolism.

Since F. nucleatum preferentially ferments amino acids, we surveyed the expression of genes involved in amino acid uptake (Fig. 2B) and metabolism (Suppl. Fig. 2) to determine which substrates might be available across each growth medium or the airway epithelial environment. Two brnQ homologs encoding branched-chain amino acid (BCAA) importers and a putP proline transporter homolog were highly expressed in control medium, moderately expressed on NHBE, and showed the lowest expression in mucin, S. oris CFS (So CFS), and NHBE co-cultures. In contrast, homologs of the azlC and azlD BCAA importer family and a sodium:alanine symporter were upregulated in mucin and So CFS. Interestingly, the symporter exhibited low expression on NHBE alone but was elevated when S. oris was co-cultured on NHBE.

Several sodium-dependent symporters and transporters were specifically induced in So CFS, while multiple ABC-type transporters and permeases were selectively upregulated in NHBE co-culture, irrespective of S. oris presence. A sodium:proton antiporter and GntP-family permease were strongly induced in NHBE co-culture, but only in the presence of S. oris, suggesting interaction-dependent metabolic shifts. Genes involved in amino acid catabolism and short-chain fatty acid production were generally upregulated in NHBE co-culture with or without S. oris. This includes genes encoding butyrate production that have recently been linked to reactive oxygen/nitrogen resistance in F. nucleatum (40). Overall, while these transcriptional patterns suggest condition-specific substrate preferences, further experimental validation will be required to define precise substrate specificities.

F. nucleatum carbohydrate metabolism is modulated by S. oris.

Although F. nucleatum is known to catabolize glucose and fructose, other carbohydrate metabolic pathways were differentially expressed in So CFS and during co-culture with S. oris on NHBE cells. Since So CFS was derived from mucin-grown cultures, any glycan degradation by S. oris could supply the component sugars to F. nucleatum. For example, the nan operon (encoding a sialic acid catabolism pathway) was strongly induced in So CFS and in NHBE co-culture (Fig. 2C). Because F. nucleatum lacks a sialidase, its access to sialic acid appears dependent on exogenous glycosidase activity from S. oris. The absence of nan induction in mucin medium supports this model.

F. nucleatum also encodes genes annotated for glycogen production and degradation, though their function has not been experimentally confirmed. These genes were minimally expressed in control and mucin media but showed increased expression in So CFS and on NHBE, particularly when co-colonized with S. oris (Fig. 2D). More broadly, many genes predicted to encode carbohydrate active enzyme (CAZyme) genes showed additional differential expression across conditions (Suppl. Fig. 3), indicating that both host- and S. oris-mediated glycan degradation may shape F. nucleatum carbohydrate utilization, including genes involved in cell wall (e.g., mrcB homolog C7Y58_RS05695) and LPS assembly/modifications (e.g., lpxCB genes).

Expression of F. nucleatum autotransporters and adhesins is modulated by nutrient and host conditions.

Virulence in F. nucleatum is mediated by several Type V autotransporters that facilitate attachment to and invasion of host cells, and modulation of immune signaling (41–45). Therefore, we evaluated the expression of all annotated autotransporter genes across each broth and host-associated condition (Suppl. Fig. 4) Expression clustered into three groups: (i) genes whose expression is highest in the control medium, (ii) those with elevated expression in mucin or So CFS (e.g., radD), and (iii) genes with maximal expression on NHBE in both mono- and co-culture. The latter group included several well-characterized F. nucleatum virulence factor genes such as fadA, cbpF, fusolisin, and fap2. An interesting exception to this grouping was fplA, which was highly expressed in control, mucin, and NHBE co-culture, but was repressed in So CFS and in co-culture with S. oris on NHBE. These data are consistent with the increasing appreciation of the connections between bacterial metabolism and regulation of virulence factors and suggest that co-colonizing S. oris could modulate fplA-mediated contributions to F. nucleatum virulence (46).

S. oris polysaccharide utilization loci (PUL) expression is responsive to both host and F. nucleatum interactions.

The S. oris genome encodes 27 PULs and one putative CAZyme cluster, some homologous to validated systems in the Bacteroides genus (47,48). Such systems are used by bacteria to sense and degrade polysaccharides typically found in plant fibers (e.g., xylan) or host glycans like mucins (49). We averaged the expression of each gene in every PUL to determine which PUL(s) respond to glycans present in mucin and on the apical surface of airway epithelial cells, as well as whether F. nucleatum supernatants or co-culture on epithelia modulate PUL expression (Fig. 3, Supplemental File 3 for ANOVA p-values). All but PUL9 were minimally expressed in control medium. Eleven PULs and the CAZyme cluster were induced in mucin medium, consistent with mucin glycan utilization. Unexpectedly, PUL expression patterns were significantly altered in Fn CFS, with decreased expression of several mucin-induced PULs and induction of multiple mucin-insensitive PULs. A third group of PULs was induced during NHBE co-culture, including PULs 3, 5, 10, 12, and 15–17, many of which were suppressed in co-culture with F. nucleatum. In contrast, PULs 4 and 25, minimally expressed in NHBE monoculture, were induced by F. nucleatum. This variable expression of PULs was anticipated between growth in mucin and control media and on NHBE, but modulation of PUL expression in Fn CFS and co-culture on NHBE was unexpected. These data suggest that F. nucleatum may influence glycan foraging by S. oris, supporting a dynamic bidirectional interaction.

S. oris encodes a putative Type VI secretion system.

Like many members of the Bacteroidota, S. oris encodes a predicted contact-dependent multi-protein Type VI secretion system (T6SS) that delivers toxins to adjacent bacteria in intensely competitive conditions (50). Given that S. oris typically resides in polymicrobial settings and therefore could plausibly benefit from such a system, we scanned the S. oris NCTC 13071 genome for T6SS genes using SecReT6 (Suppl. File 4) (51). Three genomic loci were identified, including one containing 13 clear homologs of known T6SS genes, and two smaller clusters each containing four homologs. Expression profiles (Suppl. Fig. 5) revealed moderate expression in control medium and mucin media, with higher expression of select genes in Fn CFS. The hcp homolog was only expressed in control medium, while the tssC homolog was only expressed on NHBE, irrespective of the presence of F. nucleatum. A tssI homolog (locus tag EL210_RS03325) exhibited low-to-moderate expression across broth cultures and minimal expression in monoculture on NHBE but was highly induced in NHBE co-culture with F. nucleatum, suggesting potential functional activation in response to interspecies contact. Whether these genes constitute a functional T6SS will require further experimental validation.

F. nucleatum drives airway epithelial inflammation, modulated by S. oris co-colonization.

We next profiled the transcriptional response of NHBE cells colonized for 24h with F. nucleatum or S. oris singly or in co-culture, relative to uninfected controls (Fig. 4A, Suppl. File 5). PCA analysis revealed that S. oris alone had little effect on the host transcriptome, while F. nucleatum-induced a divergent host response. Co-colonization clustered separately from F. nucleatum colonization alone, suggesting S. oris modulates epithelial responses directly or indirectly via interactions with F. nucleatum that modulate its virulence. Gene set enrichment analysis (GSEA, Fig. 4B, Suppl. Files 6 and 7) identified enrichment of inflammation- and cancer-associated pathways in F. nucleatum-colonized epithelia, including TNF-a, IL-6/JAK/STAT3 signaling, IL-2/STAT5 signaling, and Wnt/β-catenin signaling. Co-colonization altered the magnitude and composition of these responses, highlighting the influence of microbial interactions on host inflammatory signaling. Indeed, co-culture of both species on NHBE also influenced expression of genes that were uniquely enriched relative to F. nucleatum mono-colonization. This is evident in Fig. 4C,D, where some inflammatory markers were induced by F. nucleatum and did not change in co-culture (e.g., Il1β), while others were only induced in the co-culture condition (e.g., SQLE, encoding squalene epoxidase). Together, these data reveal a complex interaction between all three species that is not apparent in NHBE cells mono-colonized with either species.

Figure 4 -. Bacterial colonization alters the NHBE transcriptome.

Figure 4 -

(A) PCA plot of host transcriptomes following mono- and co-colonization with F. nucleatum and S. oris. (B) Gene set enrichment analysis (GSEA) in samples from NHBE colonized with both F. nucleatum and S. oris compared to mono-colonization with F. nucleatum (left) and NHBE mono-colonized with F. nucleatum compared to uninfected cells. Normalized enrichment scores (NES) are shown on the x-axis and the color of each point indicates false discovery rate (FDR). High NES with low FDR indicates a pathway enriched in a given comparison. Pathways enriched in both comparisons were removed from the Co-cult vs. Fn plot to highlight pathways unique to this comparison, and only those pathways with a FDR < 0.25 are shown. Expression heatmaps of transcripts enriched in (C) cells mono-colonized with F. nucleatum, or (D) cells dual-colonized with F. nucleatum and S. oris.

Discussion

The prevalence of F. nucleatum and S. oris co-colonization across multiple mucosal environments suggests potential for functional interactions that may impact bacterial colonization, persistence, and host responses. Using a combination of in vitro and host-relevant airway epithelial models, we show that these two microbes engage in bidirectional interactions involving glycan degradation, metabolite exchange, and transcriptional modulation. Although some overlaps were observed, the transcriptional profiles of both species in broth culture were markedly different from those observed during epithelial colonization. These differences were particularly evident in metabolic gene expression and the regulation of F. nucleatum virulence factors. These disparities underscore the importance of incorporating host-relevant conditions when using reductionist approaches to identify and model interactions between co-colonizing microbes.

Despite these differences, two transcriptional signals indicative of glycan-mediated interactions were observed across both culture and host-associated conditions. First, the F. nucleatum nan operon, encoding a sialic acid catabolism pathway, was not expressed in mucin medium but was highly induced in S. oris supernatants and in co-culture on NHBE cells. Given that F. nucleatum lacks sialidase activity, these data support a model in which sialic acid utilization depends on glycosidase activity from co-resident microbes. This is consistent with previous work by Agarwal et al (28), who showed that F. nucleatum exploits sialidase-positive microbes to access host-derived sialic acids in dysbiotic vaginal communities. The nan operon is not conserved across all F. nucleatum subspecies, so caution is warranted when generalizing these findings. Nevertheless, the broader concept of F. nucleatum contributing to dysbiotic bacterial community structures via cross-feeding is one that may apply to many sites of infection. Indeed, Queen et al identified F. nucleatum within polymicrobial biofilms on colorectal tumors and noted enrichment of sialic acid-adjacent metabolic pathways based on predicted metagenomic content (52).

A second glycan-associated transcriptional signal involved modulation of S. oris PULs. While several PULs were robustly induced by mucin, their expression was suppressed in the presence of F. nucleatum supernatants or during co-colonization on epithelial cells. This is notable for at least two reasons: (i) the large number of PULs affected; and (ii) the fact that F. nucleatum has not been reported to degrade host-associated glycans and is therefore not expected to alter the glycan landscape of mucin medium. The porcine gastric mucin used in this study is a crude proteolytic digest and likely contains non-mucin glycans such as glycosaminoglycans, which may explain the broad induction of PULs. For example, PULs predicted to target heparin and chondroitin (e.g., PULs 7 and 8) were induced in both mucin and on NHBE cells, but were repressed in the presence of F. nucleatum, suggesting nutrient depletion or transcriptional repression. One possible mechanism is that F. nucleatum secretes metabolic byproducts that modulate S. oris gene expression. This could include secreted polyglucose or glycogen, which could then be available to S. oris or scavenged from dead F. nucleatum cells. Notably, F. nucleatum glycogen metabolism genes were upregulated on NHBE, particularly during co-culture with S. oris, but not in mucin medium, suggesting that glycogen is unlikely to be present in Fusobacterium supernatants. Alternatively, glycosylated surface or secreted proteins from of F. nucleatum may serve as nutrient sources (53). A final possibility is that F. nucleatum encodes as-yet undescribed polysaccharide degradation and acquisition pathways that target glycans present in mucin or on epithelial cells, thereby diminishing PUL-inducing signals for S. oris.

The airway epithelial response was strongly influenced by F. nucleatum and further modulated by co-colonization with S. oris. Consistent with prior single-cell RNA-seq studies (39), F. nucleatum elicited robust inflammatory signaling, including induction of TNF-α, IL-1β, and mitochondrial stress responses suggestive of apoptosis. In contrast, S. oris alone triggered minimal host transcriptional changes, consistent with its commensal nature. Nevertheless, co-colonization with S. oris altered the epithelial response, suggesting that microbial interactions can modulate host sensing and inflammation. For example, TNS4, a gene linked to poor prognosis in lung adenocarcinoma (54), was significantly downregulated in the NHBE co-culture condition compared F. nucleatum alone. The opposite pattern is shown in Fig. 4D, where co-culture induced the expression of several genes not responsive to either bacterium alone. Because S. oris alone had minimal effect, we hypothesize that co-colonization alters F. nucleatum behavior in ways that modulate host responses. However, we cannot rule out F. nucleatum-driven changes in S. oris behavior that directly influences the airway epithelial response. Regardless, these data highlight the need to consider microbial interactions when modeling host-pathogen dynamics and support the integration of microbiome-derived hypotheses with mechanistic approaches to uncover host-pathogen-microbiome interactions.

In summary, we provide evidence that interactions between nutrient availability, the host environment, and co-colonizing bacteria shape the behavior of F. nucleatum, S. oris, and airway epithelial cells. Limitations should be acknowledged. While transcriptional and translational output are generally linked, differences between the half-life of mRNA and protein may result in temporal or spatial differences in bacterial and host behavior that are undetectable in our data. Likewise, site-directed mutagenesis is required to confirm several bacterial interactions suggested by our data, but genetic tools for F. nucleatum have only recently been developed and none are available for S. oris thus far. Lastly, we used only one strain of each bacterium in these experiments, which inherently excludes subspecies- and strain-level genetic (and thus phenotypic) diversity. Despite these limitations, our findings provide a framework for exploring glycan-driven cross-feeding and its impact on pathobiont behavior and host responses in mucosal environments.

Supplementary Material

Supplement 1
media-1.xlsx (1.5MB, xlsx)
Supplement 2
media-2.xlsx (2MB, xlsx)
Supplement 3
media-3.xlsx (46.3KB, xlsx)
Supplement 4
media-4.xlsx (16.6KB, xlsx)
Supplement 5
media-5.xlsx (15MB, xlsx)
Supplement 6
media-6.xlsx (925.4KB, xlsx)
Supplement 7
media-7.xlsx (192.8KB, xlsx)
Supplement 8
media-8.pdf (546.9KB, pdf)

Importance.

Fusobacterium nucleatum is increasingly recognized as a pathobiont in mucosal diseases, including colorectal cancers and chronic airway infections, yet its functional interactions with co-colonizing microbiota remain poorly understood. Here, we demonstrate that F. nucleatum engages in bidirectional interactions with Segatella oris, a glycan-foraging anaerobe also enriched in mucin-rich environments. Through nutrient cross-feeding, antagonism, and transcriptional modulation, these interactions shape bacterial behavior and the host epithelial response. Notably, glycan degradation by S. oris enables F. nucleatum access to sialic acids, while F. nucleatum suppresses expression of multiple polysaccharide utilization loci in S. oris, revealing a reciprocal ecological influence. Co-colonization of the airway epithelial surface also modulates gene expression linked to inflammation and cancer. These findings advance our understanding of polymicrobial dynamics at mucosal interfaces and highlight the importance of incorporating microbe-microbe-host interactions into reductionist models of infection and disease.

ACKNOWLEGEMENTS

This work was funded by the National Institute for Allergy and Infectious Diseases (AI177613), the University at Buffalo Research Foundation, and a Cystic Fibrosis Foundation postdoctoral fellowship to J.R.F. (002569F221)

REFERENCES

  • 1.Segata N.; Haake S. K.; Mannon P.; Lemon K. P.; Waldron L.; Gevers D.; Huttenhower C.; Izard J. Composition of the adult digestive tract bacterial microbiome based on seven mouth surfaces, tonsils, throat and stool samples. Genome Biol 2012, 13 (6), R42. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Loozen G.; Ozcelik O.; Boon N.; De Mol A.; Schoen C.; Quirynen M.; Teughels W. Inter-bacterial correlations in subgingival biofilms: a large-scale survey. J Clin Periodontol 2014, 41 (1), 1–10. [DOI] [PubMed] [Google Scholar]
  • 3.Kostic A. D.; Gevers D.; Pedamallu C. S.; Michaud M.; Duke F.; Earl A. M.; Ojesina A. I.; Jung J.; Bass A. J.; Tabernero J.; et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res 2012, 22 (2), 292–298. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Tahara T.; Shijimaya T.; Yamazaki J.; Kobayashi S.; Horitani A.; Matsumoto Y.; Nakamura N.; Okazaki T.; Takahashi Y.; Tomiyama T.; et al. Fusobacterium Detected in Barretťs Esophagus and Esophageal Adenocarcinoma Tissues. Cancer Invest 2024, 42 (6), 469–477. [DOI] [PubMed] [Google Scholar]
  • 5.Battaglia T. W.; Mimpen I. L.; Traets J. J. H.; van Hoeck A.; Zeverijn L. J.; Geurts B. S.; de Wit G. F.; Noë M.; Hofland I.; Vos J. L.; et al. A pan-cancer analysis of the microbiome in metastatic cancer. Cell 2024, 187 (9), 2324–2335.e2319. [DOI] [PubMed] [Google Scholar]
  • 6.Zhang J. W.; Zhang D.; Yin H. S.; Zhang H.; Hong K. Q.; Yuan J. P.; Yu B. P. promotes esophageal squamous cell carcinoma progression and chemoresistance by enhancing the secretion of chemotherapy-induced senescence-associated secretory phenotype via activation of DNA damage response pathway. Gut Microbes 2023, 15 (1), 2197836. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Lucas S. K.; Yang R.; Dunitz J. M.; Boyer H. C.; Hunter R. C. 16S rRNA gene sequencing reveals site-specific signatures of the upper and lower airways of cystic fibrosis patients. J Cyst Fibros 2018, 17 (2), 204–212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Lucas S. K.; Feddema E.; Boyer H. C.; Hunter R. C. Diversity of cystic fibrosis chronic rhinosinusitis microbiota correlates with different pathogen dominance. J Cyst Fibros 2021, 20 (4), 678–681. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Lucas S. K.; Villarreal A. R.; Ahmad M. M.; Itabiyi A.; Feddema E.; Boyer H. C.; Hunter R. C. Anaerobic Microbiota Derived from the Upper Airways Impact Staphylococcus aureus Physiology. Infect Immun 2021, 89 (9), e0015321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Thornton C. S.; Surette M. G. Potential Contributions of Anaerobes in Cystic Fibrosis Airways. J Clin Microbiol 2021, 59 (3). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Pappe E.; Hübner R. H.; Saccomanno J.; Ebrahimi H. D. N.; Witzenrath M.; Wiessner A.; Sarbandi K.; Xiong Z.; Kursawe L.; Moter A.; et al. Biofilm infections of endobronchial valves in COPD patients after endoscopic lung volume reduction: a pilot study with FISHseq. Sci Rep 2024, 14 (1), 23078. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Choi Y. J.; Park H. J.; Kim C. Y.; Choi A.; Cho J. H.; Byun M. K. Dynamic microbial changes in exacerbation of chronic obstructive pulmonary disease. Front Microbiol 2024, 15, 1507090. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Bahetjan K.; Yu-Xia; Lin S.; Aili N.; Yang H.; Du S. Analysis of the bronchoalveolar lavage fluid microbial flora in COPD patients at different lung function during acute exacerbation. Sci Rep 2025, 15 (1), 13179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Farrell H.E.; Shaw J.G., Goh F; Bowman R.V; Fong K.M.; Krause L.; Yang I.A. Potential clinical utility of multiple target quantitative polymerase chain reaction (qPCR) array to detect microbial pathogens in patients with chronic obstructive pulmonary disease (COPD). J Thorac Dis. 2019. 11(S17), S2254–S2265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Hendrickson E. L.; Wang T.; Beck D. A.; Dickinson B. C.; Wright C. J.; J Lamont R.; Hackett M. Proteomics of Fusobacterium nucleatum within a model developing oral microbial community. Microbiologyopen 2014, 3 (5), 729–751. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Zelasko S.; Swaney M. H.; Sandstrom S.; Lee K. E.; Dixon J.; Riley C.; Watson L.; Godfrey J. J.; Ledrowski N.; Rey F.; et al. Early-life upper airway microbiota are associated with decreased lower respiratory tract infections. J Allergy Clin Immunol 2025, 155 (2), 436–450. [DOI] [PubMed] [Google Scholar]
  • 17.Sato T., Kamaguchi A; Nazakawa F. The release of glyceraldehyde-3-phosphoate dehydrogenase (GAPDH) from human erythrocyte membranes lysed by hemolysin of Prevotella oris. Anaerobe 2012, 18(5), 553–555. [DOI] [PubMed] [Google Scholar]
  • 18.Hong B. Y.; Sobue T.; Choquette L.; Dupuy A. K.; Thompson A.; Burleson J. A.; Salner A. L.; Schauer P. K.; Joshi P.; Fox E.; et al. Chemotherapy-induced oral mucositis is associated with detrimental bacterial dysbiosis. Microbiome 2019, 7 (1), 66. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Dicksved J.; Lindberg M.; Rosenquist M.; Enroth H.; Jansson J. K.; Engstrand L. Molecular characterization of the stomach microbiota in patients with gastric cancer and in controls. J Med Microbiol 2009, 58 (Pt 4), 509–516. [DOI] [PubMed] [Google Scholar]
  • 20.Greathouse K. L.; Stone J. K.; Vargas A. J.; Choudhury A.; Padgett R. N.; White J. R.; Jung A.; Harris C. C. Co-enrichment of cancer-associated bacterial taxa is correlated with immune cell infiltrates in esophageal tumor tissue. Sci Rep 2024, 14 (1), 2574. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.McCoy A; Araujo-Perez F; Azcarte-Peril A.; Yeh J. J.; Sandler R.S.; Keku T.O. Fusobacterium is associated with colorectal adenomas. PLoS One, 2013, 8(1),e53653. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Dzink J. L.; Socransky S. S. Amino acid utilization by Fusobacterium nucleatum grown in a chemically defined medium. Oral Microbiol Immunol 1990, 5 (3), 172–174. [DOI] [PubMed] [Google Scholar]
  • 23.Zilm P. S.; Gully N. J.; Rogers A. H. Growth pH and transient increases in amino acid availability influence polyglucose synthesis by Fusobacterium nucleatum grown in continuous culture. FEMS Microbiol Lett 2002, 215 (2), 203–208. [DOI] [PubMed] [Google Scholar]
  • 24.Rogers A.H.; Chen J.; Zilm P.S.; Gully N.J. The behavior of Fusobacterium nucleatum chemostat-grown in glucose- and amino acid-based chemically defined media. Anaerobe 1998, 4(2), 111–116. [DOI] [PubMed] [Google Scholar]
  • 25.Zilm P. S.; Gully N. J.; Rogers A. H. Changes in growth and polyglucose synthesis in response to fructose metabolism by Fusobacterium nucleatum grown in continuous culture. Oral Microbiol Immunol 2003, 18 (4), 260–262. [DOI] [PubMed] [Google Scholar]
  • 26.Rogers A. H.; Zilm P. S.; Gully N. J.; Pfennig A. L.; Marsh P. D. Aspects of the growth and metabolism of Fusobacterium nucleatum ATCC 10953 in continuous culture. Oral Microbiol Immunol 1991, 6 (4), 250–255. [DOI] [PubMed] [Google Scholar]
  • 27.Rogers A. H.; Zilm P. S. The influence of intracellular polyglucose and prior growth rate on the survival of Fusobacterium nucleatum under starvation conditions. Oral Microbiol Immunol 1995, 10 (2), 119–121. [DOI] [PubMed] [Google Scholar]
  • 28.Agarwal K.; Robinson L.S.; Aggarwal S.; Foster L.R.; Hernandez-Leyva A. et al. Glycan cross-feeding supports mutualism between Fusobacterium and the vaginal microbiota. PloS Biology, 2020, 18(8), e3000788. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Terrapon N.; Lombard V.; Gilbert H. J.; Henrissat B. Automatic prediction of polysaccharide utilization loci in Bacteroidetes species. Bioinformatics 2015, 31 (5), 647–655. [DOI] [PubMed] [Google Scholar]
  • 30.Terrapon N.; Lombard V.; Drula É.; Lapébie P.; Al-Masaudi S.; Gilbert H. J.; Henrissat B. PULDB: the expanded database of Polysaccharide Utilization Loci. Nucleic Acids Res 2018, 46 (D1), D677–D683. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Marsili E.; Rollefson J. B.; Baron D. B.; Hozalski R. M.; Bond D. R. Microbial biofilm voltammetry: direct electrochemical characterization of catalytic electrode-attached biofilms. Appl Environ Microbiol 2008, 74 (23), 7329–7337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Flynn J. M.; Niccum D.; Dunitz J. M.; Hunter R. C. Evidence and Role for Bacterial Mucin Degradation in Cystic Fibrosis Airway Disease. PLoS Pathog 2016, 12 (8), e1005846. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Merritt J. H.; Kadouri D. E.; O'Toole G. A. Growing and analyzing static biofilms. Curr Protoc Microbiol 2005, Chapter 1, Unit 1B.1. DOI: 10.1002/9780471729259.mc01b01s00. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Williams C. R.; Baccarella A.; Parrish J. Z.; Kim C. C. Trimming of sequence reads alters RNA-Seq gene expression estimates. BMC Bioinformatics 2016, 17, 103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Patro R.; Duggal G.; Love M. I.; Irizarry R. A.; Kingsford C. Salmon provides fast and bias-aware quantification of transcript expression. Nat Methods 2017, 14 (4), 417–419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Soneson C.; Love M. I.; Robinson M. D. Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences. F1000Res 2015, 4, 1521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Love M. I.; Huber W.; Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 2014, 15 (12), 550. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Kaplan C. W.; Lux R.; Haake S. K.; Shi W. The Fusobacterium nucleatum outer membrane protein RadD is an arginine-inhibitable adhesin required for inter-species adherence and the structured architecture of multispecies biofilm. Mol Microbiol 2009, 71 (1), 35–47. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Moore P.J.; Hoffman K.; Ahmed S.; Fletcher J.R.; Wiggen T.D. et al. Dual oxic-anoxic co-culture enables direct study of anaerobe-host inteactions at the airway epithelial interface. mBio, 2025, 16(5):e0133824. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Bystrom L.T.; Wohlers K.R. New electron-transfer chain to a flavodiiron protein in Fusobacterium nucleatum couples butyryl-coA oxidation to O2 reduction. Biochemistry, 2024, 63(18), 2352–2368. [DOI] [PubMed] [Google Scholar]
  • 41.Casasanta M.A.; Yoo C.C.; Smith H.B.; Duncan A.J.; Cochrane K.; et al. A chemical and biological toolbox for Type Vd secretion: Characterization of the pshopholipase A1 autotransporter FplA from Fusoabacterium nucleatum. J. Biol. Chem. 2017, 292(49), 20240–20254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Doron L.; Coppenhagen-Glazer S.; Ibrahim Y.; Eini A.; Naor R. Identification and characterization of fusolisin, the Fusobacterium nucleatum autotransporter serine protease. PLoS One, 2014, 9(10):e111329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Gur C.; Ibrahim Y.; Isaacson B.; Yamin R.; Abed J.; et al. Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity, 2015, 42(2), 344–355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Abed J., Emgard J.E.; Zamir G.; Faroja M.; Almogy G.; et al. Fap2 mediates Fusobacterium nucleatum colorectal adenocarcinoma enrichment by binding to tumor-expressed Gal-GalNAc. Cell Host Microb, 2016, 20(2), 215–225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Meng Q.; Gao Q.; Mehrazarin S.; Tangwanichgapong K.; Wang Y; et al. Fusobacterium nucleatum secretes amyloid-like FadA to enhance pathogenicity. EMBO Rep, 2021, 22(7):e52891. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Rohmer L.; Hocquet D.; Miller S.I. Are pathogenic bacteria just looking for food? Metabolism and microbial pathogenesis. Trends Microbiol 2011, 19(7), 341–348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Drula E.; Garron M.L.; Dogan S.; Lombard V.;Henrissat B.; et al. Carbohydrate-active enzyme database: functions and literature. Nucleic Acids Res, 2022, 50(D1), D571–577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Zhang J.; Ge Q.; Yan Y.; Zhang X.; Huang L; et al. dbCAN3: automated carbohydrate-active enzyme and substrate annotation. Nucleic Acids Res, 2023, 51(W1):W115–W121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Glowacki R.W.P.; Martens E.C. If you eat it, or secrete it, they will grow: the expanding list of nutrients utilized by human gut bacteria. J Bacteriol, 2020, 203(9), e00481–20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Coyne M.J.; Comstock L.E. Type VI Secretion Systems and the Gut Microbiota. Microbiol. Spectr, 2019, 7(2), 10.1128/microbiolspec.psib-0009-2018 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Zhang J.; Guan J.; Wang M.; Li G.; Djordjevic M.; et al. 2023. SecReT6 update: a comprehensive resource of bacterial Type VI Secretion Systems. Sci China Life Sci. 66(3), 626–634. [DOI] [PubMed] [Google Scholar]
  • 52.Queen J.; Cing Z.; Minsky H.; Nandi A.; Southward T.; et al. Fusobacterium nucleatum is enriched in invasive biofilms in colorectal cancer. NPJ Biofilms Microbiomes, 2025, 11(1), 81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Yi S.; Liu Y.; Wu Q.; Zhao D.; Li Z.; et al. Glycosylation of oral bacteria in modulating adhesion and biofilm formation. J Oral Microbiol, 2025, 17(1):2486650. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Liu F.; Gao X.; Liu W.; Xue W. Mining TCGA and GEO databases for the prediction of poor prognosis in lung adenocarcinoma based on up-regulated expression of TNS4. Medicine, 2022, 101(42), e31120. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplement 1
media-1.xlsx (1.5MB, xlsx)
Supplement 2
media-2.xlsx (2MB, xlsx)
Supplement 3
media-3.xlsx (46.3KB, xlsx)
Supplement 4
media-4.xlsx (16.6KB, xlsx)
Supplement 5
media-5.xlsx (15MB, xlsx)
Supplement 6
media-6.xlsx (925.4KB, xlsx)
Supplement 7
media-7.xlsx (192.8KB, xlsx)
Supplement 8
media-8.pdf (546.9KB, pdf)

Data Availability Statement

All sequencing files are available at the NCBI Sequence Read Archive (SRA) under accession number PRJNAXXXXX.


Articles from bioRxiv are provided here courtesy of Cold Spring Harbor Laboratory Preprints

RESOURCES